Click here to go to the previous page
Communicating Your Story: Dual Path Exit Strategies
Program Code:
3082
Date:
Tuesday, May 19, 2009
Time:
2:00 PM to 3:30 PM
EST
SPEAKER
(S):
Robert Carey, Managing Director, Healthcare Investment Banking, JMP Securities LLC
Jeff Frick, MBA, Chief Business Officer, Agile Therapeutics, Inc
Donna LaVoie, President & CEO , LaVoie Strategic Communications Group, Inc.
Charles Rowland, Vice President, Chief Financial Officer, ViroPharma, Inc
Jeffrey Sandman, JD, MPA, CEO, Hyde Park Communications
Corinne Savill, PhD, Global Head, BD & L Search & Evaluation, Novartis Institutes for Biomedical Research
Description
This panel discussion will present a strategic communications blueprint for pharmaceutical and biotech firms struggling with an unstable international financial climate. Featuring panelists representing venture capitalists, biotech and pharmaceutical companies and life science communications specialists, the presentations and panel members will engage in a dialogue about the communication challenges facing the biotech and pharmaceutical industries and how best to reach a wide array of stakeholders including investors, key opinion leaders, venture capitalists, consumers and other customers.
• Provide a practical framework to communicate across all audiences around a dual path financial exit strategy
• Provide pharmaceutical and biotech firms the current state of play in the financial markets
• Share real world case experiences and best practices from an array of different perspectives